Drug Therapy

1. Use of metformin in polycystic ovary syndrome: a meta-analysis.

Author
Creanga AA; Bradley HM; McCormick C; Witkop CT;
Institution
Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. acreanga@jhsph.edu
Journal
Obstet Gynecol. 2008 Apr;111(4):959-68.
Abstract URL
Click here to view abstract

2. Acarbose for polycystic ovary syndrome.

Author
Kircher C; Smith KP;
Institution
College of Pharmacy, University of Southern Nevada, Henderson, NV 89104, USA.
Journal
Ann Pharmacother. 2008 Jun;42(6):847-51. Epub 2008 May 6.
Abstract URL
Click here to view abstract

3. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.

Author
Tan S; Hahn S; Benson S; Dietz T; Lahner H; Moeller LC; Schmidt M; Elsenbruch S; Kimmig R; Mann K; Janssen OE;
Institution
Division of Endocrinology, Department of Medicine, University Hospital of Essen Medical School, Hufelandstr. 55, 45122 Essen, Germany. susanne.tan@uk-essen.de
Journal
Eur J Endocrinol. 2007 Nov;157(5):669-76.
Abstract URL
Click here to view abstract

4. Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis.

Author
Sharma ST; Wickham EP 3rd; Nestler JE;
Institution
The Division of Endocrinology and Metabolism, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia 23298-0111, USA.
Journal
Endocr Pract. 2007 Jul-Aug;13(4):373-9.
Abstract URL
Click here to view abstract

5. Pharmacologic therapy of polycystic ovary syndrome.

Author
Dronavalli S; Ehrmann DA;
Institution
Department of Medicine, Section of Endocrinology, Diabetes, and Metabolism, The University of Chicago, Chicago, Illinois, USA.
Journal
Clin Obstet Gynecol. 2007 Mar;50(1):244-54.
Abstract URL
Click here to view abstract

6. N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study.

Author
Elnashar A; Fahmy M; Mansour A; Ibrahim K;
Institution
Department of Obstetrics and Gynecology, Benha University Hospital, Benha, Egypt.
Journal
Fertil Steril. 2007 Feb 28;.
Abstract URL
Click here to view abstract

7. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.

Author
Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM;
Institution
Department of Obstetrics and Gynecology, University of Modena and Reggio Emilia, Modena, Italy. algen@unimo.it
Journal
Gynecol Endocrinol. 2007 Mar;23(3):146-52.
Abstract URL
Click here to view abstract

8. Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.

Author
Luque-Ramirez M; Alvarez-Blasco F; Botella-Carretero JI; Martinez-Bermejo E; Lasuncion MA; Escobar-Morreale HF;
Institution
Departments of Endocrinology (M.L.-R., F.A.-B., J.I.B.-C., E.M.-B., H.F.E.-M.) and Biochemistry-Research (M.A.L.), Hospital Universitario Ramon y Cajal & Universidad de Alcala, Madrid, Spain and CIBER Fisiologia Obesidad y Nutricion (CB06/03), Instituto de Salud Carlos III (M.A.L.).
Journal
J Clin Endocrinol Metab. 2007 Apr 10;.
Abstract URL
Click here to view abstract

9. Cardiovascular risk factors are reduced with a low dose of acarbose in obese patients with polycystic ovary syndrome.

Author
Penna IA; Canella PR; Vieira CS; Silva de Sa MF; Reis RM; Ferriani RA;
Institution
Department of Obstetrics and Gynecology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil; Gynecology Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Journal
Fertil Steril. 2007 Apr 5;.
Abstract URL
Click here to view abstract